These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10572546)

  • 1. Breast cancer screening.
    Sirovich BE; Sox HC
    Surg Clin North Am; 1999 Oct; 79(5):961-90. PubMed ID: 10572546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing the benefits of screening mammography for women 40-49 years old.
    Bastardis-Zakas K; Iatrakis G; Navrozoglou I; Peitsidis P; Salakos N; Malakassis P; Zervoudis S
    Clin Exp Obstet Gynecol; 2010; 37(4):278-82. PubMed ID: 21355457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of breast cancer screening by mammography in younger women.
    Elwood JM; Cox B; Richardson AK
    Online J Curr Clin Trials; 1993 Feb; Doc No 32():[23,227 words; 195 paragraphs]. PubMed ID: 8305999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age.
    Black WC; Nease RF; Tosteson AN
    J Natl Cancer Inst; 1995 May; 87(10):720-31. PubMed ID: 7563149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of benefits and harms of breast cancer screening with age.
    Harris R
    J Natl Cancer Inst Monogr; 1997; (22):139-43. PubMed ID: 9709290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
    J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of screening mammography: a review for the primary care physician.
    Reichle JL
    South Med J; 1998 Jun; 91(6):510-7. PubMed ID: 9634110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
    Salzmann P; Kerlikowske K; Phillips K
    Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based mammographic screening: does 'informed choice' require any less than full disclosure to individuals of benefits, harms, limitations and consequences?
    Ward J
    Aust N Z J Public Health; 1999 Jun; 23(3):301-4. PubMed ID: 10388176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Fu R; Cantor A; Pappas M; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):244-55. PubMed ID: 26756588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.